Meet Abenaa Brewster, M.D.
Abenaa M. Brewster, M.D., M.H.S.
Department of Clinical Cancer Prevention, Division of Cancer Prevention and Population Sciences
About Dr. Brewster
Dr. Abenaa Brewster is a tenured Professor in the Department of Clinical Cancer Prevention at MD Anderson Cancer Center and has an adjunct appointment in the Department of Epidemiology. She is a medical oncologist, Director of the MD Anderson Nellie B. Connally Breast Center, and her clinical interest is the management of breast cancer. Her research team has developed a framework for investigating the decision-making process that women undergo in considering contralateral prophylactic mastectomy. Her research expertise involves using the tools of molecular epidemiology to investigate clinical, epidemiological and biological factors that determine breast cancer risk and survival. She is particularly interested in understanding how tumor genomics, host genetic susceptibility, ethnicity, and obesity influence a woman's risk and survival after a diagnosis of breast cancer. She has experience in the conduct and data management of hospital, population-based cohort studies, and is the principal investigator and director of a longitudinal cohort study of women at high risk of developing breast cancer. Dr. Brewster is a Komen Scholar, an award given to individuals for their knowledge and leadership within the scientific, research and advocacy communities and for their own contribution to breast cancer research.
Present Title & Affiliation
Primary Appointment
Professor (Tenured), Department of Clinical Cancer Prevention, Division of OVP, Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center. 09/2015 to present, Houston, TX
Medical Director, Nellie B. Connally Breast Center, The University of Texas MD Anderson Cancer Center, Houston, TX
Clinical Medical Director, Department of Breast Medical Oncology, Division of Cancer Medicine, Breast Medical Oncology Clinic, The University of Texas MD Anderson Cancer Center. 04/2002 to present, Houston, TX
Education & Training
Degree-Granting Education
| 2001 | Johns Hopkins School of Hygiene & Public Health, Baltimore, MD, USA, Master of Health Science, Cancer Epidemiology |
| 1995 | Harvard Medical School, Boston, MA, USA, MD, Medicine |
| 1990 | Stanford University, Stanford, CA, USA, BS, Chemistry |
Board Certifications
| 2012 | Medical Oncology, American Board of Internal Medicine |
Experience & Service
Academic Appointments
Associate Professor (Tenured), Department of Epidemiology, Division of OVP, Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, 2009 - 2015
Assistant Professor, Department of Epidemiology, Division of OVP, Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, 2002 - 2009
Institutional Committee Activities
Member, GAP Africa Faculty Working Group, 2013 - Present
Member, Clinical Research Advisory Committee, 2012 - Present
Member, Clinical Research Committee, 2012 - 2019
Member, Duncan Fund Institute Clinical Cancer Prevention Research Core Steering Committee, 2011 - Present
Member, Clinical Revenue Cycle Committee, 2011 - 2012
Member, Advisory Committee for the Patient-reported Outcomes, Survey & Population Research (PROSPR) Shared Resource, The University of Texas MD Anderson Cancer Center, 2009 - Present
Member, Breast Tissue Oversight Committee, 2009 - Present
Honors & Awards
| 2023 | Fellows of the American Society of Clinical Oncology, American Society of Clinical Oncology |
| 2010 | Seminar Attendee, Association of American Medical College's (AAMC) Mid-Career Women's Faculty Development |
| 2008 | Seminar Attendee, Association of American Medical College's (AAMC) Early Career Women's Faculty Development |
| 2003 | Young Investigator Award, American Society of Clinical Oncology |
| 2003 | Clinical Research Loan Repayment Program, National Institutes of Health |
| 2001 | Honorable Mention (2nd place) for Clinical Research, Johns Hopkins Cancer Center Fellows Research Day |
| 1994 | Slack Award for Student Medical Research, National Medical Association |
| 1993 | Karen Grunebaum Oncology Fellowship, Karen Grunebaum Foundation |
| 1993 | Second Place Award for Student Abstracts, American Gastroenterology Association |
| 1990 | STARR Foundation Graduate Academic Scholarship, STARR Foundation |
| 1986 | Dean's List, Rutgers University |
| 1986 | STARR Foundation Undergraduate Academic Scholarship, STARR Foundation |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Gapstur SM, Bandera EV, Jernigan DH, LoConte NK, Southwell BG, Vasiliou V, Brewster AM, Naimi TS, Scherr CL, Shield KD. Alcohol and Cancer: Existing Knowledge and Evidence Gaps Across the Cancer Continuum. Cancer Epidemiol Biomarkers Prev 31(1):5-10, 2022. e-Pub 2021. PMID: 34728469.
- Robertson MC, Cox-Martin E, Liao Y, Flores SA, Shegog R, Markham CM, Fujimoto K, Durand CP, Brewster A, Lyons EJ, Basen-Engquist KM. Acceptance- and mindfulness-based techniques for physical activity promotion in breast cancer survivors: a qualitative study. Support Care Cancer. e-Pub 2021. PMID: 34313858.
- Advani P, Advani S, Nayak P, VonVille HM, Diamond P, Burnett J, Brewster AM, Vernon SW. Racial/ethnic disparities in use of surveillance mammogram among breast cancer survivors: a systematic review. J Cancer Surviv. e-Pub 2021. PMID: 33982233.
- Smith-Graziani DJ, Parker PA, Peterson SK, Bedrosian I, Shen Y, Black DM, DeSnyder SM, Hunt KK, Dong W, Brewster AM. Prospective Study of Pain Outcomes Associated with Breast Surgery in Women with Nonhereditary Breast Cancer. Ann Surg. e-Pub 2021. PMID: 33938495.
- Singareeka Raghavendra A, Alameddine HF, Andersen CR, Selber JC, Brewster AM, Barcenas CH, Caudle AS, Arun BK, Tripathy D, Ibrahim NK. Influencers of the Decision to Undergo Contralateral Prophylactic Mastectomy among Women with Unilateral Breast Cancer. Cancers (Basel) 13(9), 2021. e-Pub 2021. PMID: 33922702.
- Ligibel JA, Jones LW, Brewster AM, Clinton SK, Korde LA, Oeffinger KC, Bender CM, Tan W, Merrill JK, Katta S, Alfano CM. Oncologists' Attitudes and Practice of Addressing Diet, Physical Activity, and Weight Management With Patients With Cancer: Findings of an ASCO Survey of the Oncology Workforce. J Oncol Pract 15(6):e520-e528, 2019. e-Pub 2019. PMID: 31095436.
- Davies KR, Cantor SB, Brewster AM. Better contralateral breast cancer risk estimation and alternative options to contralateral prophylactic mastectomy. Int J Womens Health 7:181-187, 2015. e-Pub 2015. PMID: 25678823.
- Kogawa T, Fouad TM, Wei C, Masuda H, Kai K, Fujii T, El-Zein R, Chavez-MacGregor M, Litton JK, Brewster A, Alvarez RH, Hortobagyi GN, Valero V, Theriault R, Ueno NT. Association of body mass index changes during neoadjuvant chemotherapy with pathologic complete response and clinical outcomes in patients with locally advanced breast cancer. J Cancer 6(4):310-318, 2015. e-Pub 2015. PMID: 25767600.
- Schover LR, Baum GP, Fuson LA, Brewster A, Melhem-Bertrandt A. Sexual problems during the first 2 years of adjuvant treatment with aromatase inhibitors. J Sex Med 11(12):3102-11, 2014. e-Pub 2014. PMID: 25141792.
- Brewster AM, Chavez-MacGregor M, Brown P. Epidemiology, biology, and treatment of triple-negative breast cancer in women of African ancestry. Lancet Oncol 15(13):e625 - e634, 2014. e-Pub 2014. PMID: 25456381.
- Deshmukh AA, Cantor SB, Crosby MA, Dong W, Shen Y, Bedrosian I, Peterson SK, Parker PA, Brewster AM. Cost of contralateral prophylactic mastectomy. Ann Surg Oncol 21(9):2823-30, 2014. e-Pub 2014. PMID: 24809301.
- Pande M, Bondy ML, Do KA, Sahin AA, Ying J, Mills GB, Thompson PA, Brewster AM. Association between germline single nucleotide polymorphisms in the PI3K-AKT-mTOR pathway, obesity, and breast cancer disease-free survival. Breast Cancer Res Treat 147(2):381-7, 2014. e-Pub 2014. PMID: 25108739.
- Nodora JN, Gallo L, Cooper R, Wertheim BC, Natarajan L, Thompson PA, Komenaka IK, Brewster A, Bondy M, Daneri-Navarro A, Meza-Montenegro MM, Gutierrez-Millan LE, Martínez ME. Reproductive and hormonal risk profile according to language acculturation and country of residence in the Ella Binational Breast Cancer Study. J Womens Health (Larchmt) 23(6):532-40, 2014. e-Pub 2014. PMID: 24475760.
- Gonzalez-Angulo AM, Akcakanat A, Liu S, Green MC, Murray JL, Chen H, Palla SL, Koenig KB, Brewster AM, Valero V, Ibrahim NK, Moulder-Thompson S, Litton JK, Tarco E, Moore J, Flores P, Crawford D, Dryden MJ, Symmans WF, Sahin A, Giordano SH, Pusztai L, Do KA, Mills GB, Hortobagyi GN, Meric-Bernstam F. Open label randomized clinical trial of standard neoadjuvant chemotherapy with paclitaxel followed by FEC vs. the combination of paclitaxel and everolimus followed by FEC in women with triple receptor-negative breast cancer. Ann Oncol 25(6):1122-7, 2014. e-Pub 2014. PMID: 24669015.
- Advani PS, Ying J, Theriault R, Melhem-Bertrand A, Moulder S, Bedrosian I, Tereffe W, Black S, Pini TM, Brewster AM. Ethnic disparities in adherence to breast cancer survivorship surveillance care. Cancer 120(6):894-900, 2014. e-Pub 2013. PMID: 24258799.
- Liu Y, Zhou R, Baumbusch LO, Tsavachidis S, Brewster AM, Do KA, Sahin A, Hortobagyi GN, Taube JH, Mani SA, Aarøe J, Wärnberg F, Børresen-Dale AL, Mills GB, Thompson PA, Bondy ML. Genomic copy number imbalances associated with bone and non-bone metastasis of early-stage breast cancer. Breast Cancer Res Treat 143(1):189-201, 2014. e-Pub 2013. PMID: 24305980.
- Anderson K, Thompson PA, Wertheim BC, Martin L, Komenaka IK, Bondy M, Daneri-Navarro A, Meza-Montenegro MM, Gutierrez-Millan LE, Brewster A, Madlensky L, Tobias M, Natarajan L, Martínez ME. Family history of breast and ovarian cancer and triple negative subtype in hispanic / Latina women. Springerplus 3:727, 2014. e-Pub 2014. PMID: 25713754.
- Martinez ME, Wertheim BC, Natarajan L, Schwab R, Bondy M, Daneri-Navarro A, Meza-Montenegro MM, Gutierrez-Millan LE, Brewster A, Komenaka IK, Thompson PA. Reproductive factors, heterogeneity and breast tumor subtypes in women of mexican descent. Cancer Epidemiol Biomarkers Prev 22(10):1853-61, 2013. e-Pub 2013. PMID: 23950213.
- Atkinson RL, Yang WT, Rosen DG, Landis MD, Wong H, Lewis MT, Creighton CJ, Sexton KR, Hilsenbeck SG, Sahin AA, Brewster AM, Woodward WA, Chang JC. Cancer stem cell markers are enriched in normal tissue adjacent to triple negative breast cancer and inversely correlated with DNA repair deficiency. Breast Cancer Res 15(5):R77, 2013. PMID: 24008095.
- Gonzalez-Angulo AM, Akcakanat A, Liu S, Green MC, Murray JL, Chen H, Palla SL, Koenig KB, Brewster AM, Valero V, Ibrahim NK, Moulder-Thompson S, Litton JK, Tarco E, Moore J, Flores P, Crawford D, Dryden MJ, Symmans WF, Sahin A, Giordano SH, Pusztai L, Do KA, Mills GB, Hortobagyi GN, Meric-Bernstam F. An open-label safety study of lapatinib plus trastuzumab plus paclitaxel in first-line HER2-positive metastatic breast cancer. Oncologist 18(6):661-6, 2013. e-Pub 2013. PMID: 23697602.
- Martínez ME, Pond E, Wertheim BC, Nodora JN, Jacobs ET, Bondy M, Daneri-Navarro A, Meza-Montenegro MM, Gutierrez-Millan LE, Brewster A, Komenaka IK, Thompson P. Association between parity and obesity in Mexican and Mexican-American women: findings from the Ella Binational breast cancer study. J Immigr Minor Health 15(2):234-243, 2013. e-Pub 2012. PMID: 22618357.
- Murray JL, Thompson P, Yoo SY, Do KA, Pande M, Zhou R, Liu Y, Sahin AA, Bondy ML, Brewster AM. Prognostic value of single nucleotide polymorphisms of candidate genes associated with inflammation in early stage breast cancer. Breast Cancer Res Treat 138(3):917-924, 2013. e-Pub 2013. PMID: 23529385.
- Pande M, Thompson PA, Do KA, Sahin AA, Amos CI, Frazier ML, Bondy ML, Brewster AM. Genetic variants in the vitamin D pathway and breast cancer disease-free survival. Carcinogenesis 34(3):587-94, 2013. e-Pub 2012. PMID: 23180655.
- Bailes AA, Kuerer HM, Lari SA, Jones LA, Brewster AM. Impact of race and ethnicity on features and outcome of ductal carcinoma in situ of the breast. Cancer 119(1):150-7, 2013. e-Pub 2012. PMID: 22736444.
- Cruz GI, Martínez ME, Natarajan L, Wertheim BC, Gago-Dominguez M, Bondy M, Daneri-Navarro A, Meza-Montenegro MM, Gutierrez-Millan LE, Brewster A, Schedin P, Komenaka IK, Castelao JE, Carracedo A, Redondo CM, Thompson PA. Hypothesized role of pregnancy hormones on HER2+ breast tumor development. Breast Cancer Res Treat 137(1):237-46, 2013. e-Pub 2012. PMID: 23135573.
- Bayraktar S, Thompson PA, Yoo SY, Do KA, Sahin AA, Arun BK, Bondy ML, Brewster AM. The relationship between eight GWAS-identified single-nucleotide polymorphisms and primary breast cancer outcomes. Oncologist 18(5):493-500, 2013. e-Pub 2013. PMID: 23635555.
- Brewster AM, Bedrosian I, Parker PA, Dong W, Peterson SK, Cantor SB, Crosby M, Shen Y. Association between contralateral prophylactic mastectomy and breast cancer outcomes by hormone receptor status. Cancer 118(22):5637-43, 2012. e-Pub 2012. PMID: 22517269.
- Kuerer HM, Lari SA, Arun BK, Hu CY, Brewster A, Mittendorf EA, Albarracin CT, Babiera GV, Caudle AS, Wagner JL, Litton JK, Bedrosian I, Meric-Bernstam F, Lucci A, Hunt KK. Biologic features and prognosis of ductal carcinoma in situ are not adversely impacted by initial large body mass. Breast Cancer Res Treat 133(3):1131-1141, 2012. e-Pub 2012. PMID: 22392043.
- Moulder S, Gladish G, Ensor J, Gonzalez-Angulo AM, Cristofanilli M, Murray JL, Booser D, Giordano SH, Brewster A, Moore J, Rivera E, Hortobagyi GN, Tran HT. A phase 1 study of weekly everolimus (RAD001) in combination with docetaxel in patients with metastatic breast cancer. Cancer 118(9):2378-84, 2012. e-Pub 2011. PMID: 22006179.
- Dominici LS, Mittendorf EA, Wang X, Liu J, Kuerer HM, Hunt KK, Brewster A, Babiera GV, Buchholz TA, Meric-Bernstam F, Bedrosian I. Implications of constructed biologic subtype and its relationship to locoregional recurrence following mastectomy. Breast Cancer Res 14(3):R82, 2012. e-Pub 2012. PMID: 22621306.
- Wang LE, Han CH, Xiong P, Bondy ML, Yu TK, Brewster AM, Shete S, Arun BK, Buchholz TA, Wei Q. Gamma-ray-induced mutagen sensitivity and risk of sporadic breast cancer in young women: a case-control study. Breast Cancer Res Treat 132(3):1147-55, 2012. e-Pub 2012. PMID: 22218884.
- Arun BK, Valero V, Liu D, Brewster AM, Green M, Gutierrez-Barrera AM, Akar U, Rivera E, Esteva FJ, Buzdar AU, Hortobagyi GN, Sneige N. Short-term biomarker modulation prevention study of Anastrozole in Women at increased risk for second primary breast cancer. Cancer Prev Res (Phila) 5(2):276-82, 2012. e-Pub 2011. PMID: 22102688.
- Garcia RZ, Carvajal SC, Wilkinson AV, Thompson PA, Nodora JN, Komenaka IK, Brewster A, Cruz GI, Wertheim BC, Bondy ML, Martinez ME. Factors that influence mammography use and breast cancer. Cancer Causes Control 23(1):165-73, 2012. PMID: 22080276.
- Del Fabbro E, Parsons H, Warneke CL, Pulivarthi K, Litton JK, Dev R, Palla SL, Brewster A, Bruera E. The relationship between body composition and response to neoadjuvant chemotherapy in women with operable breast cancer. Oncologist 17(10):1240-5, 2012. e-Pub 2012. PMID: 22903527.
- Brewster AM, Etzel C, Zhou R, Wong Y, Edge S, Blayney DW, Wilson J, Hudis C, Ottesen R, Hughes ME, Weeks JC, Theriault RL. The impact of obesity on receipt of adjuvant chemotherapy for breast cancer in the National Comprehensive Cancer Network (NCCN) centers. Breast Cancer Res Treat 130(3):897-904, 2011. e-Pub 2011. PMID: 21809116.
- Brewster AM, Thompson P, Sahin AA, Do K, Edgerton M, Murray JL, Tsavachidis S, Zhou R, Liu Y, Zhang L, Mills G, Bondy M. Copy number imbalances between screen and symptom-detected breast cancers and impact on disease-free survival. Cancer Prev Res (Phila) 4(10):1609-16, 2011. e-Pub 2011. PMID: 21795423.
- Zhang G, Brewster A, Guan B, Fan Z, Brown PH, Xu XC. Tumor-suppressor activity of RRIG1 in breast cancer. BMC Cancer 11:32, 2011. e-Pub 2011. PMID: 21266059.
- Brewster AM, Parker PA. Current knowledge on contralateral prophylactic mastectomy among women with sporadic breast cancer. Oncologist 16(7):935-41, 2011. e-Pub 2011. PMID: 21672945.
- Thompson PA, Brewster AM, Kim-Anh D, Baladandayuthapani V, Broom BM, Edgerton ME, Hahn KM, Murray JL, Sahin A, Tsavachidis S, Wang Y, Zhang L, Hortobagyi GN, Mills GB, Bondy ML. Selective genomic copy number imbalances and probability of recurrence in early-stage breast cancer. PLos ONE. PLoS One 6(8):e23543, 2011. e-Pub 2011. PMID: 21858162.
Manuals, Teaching Aids, Other Teaching Publications
- Brewster AM. Male Breast Cancer Part 2, 2002.
- Brewster AM. Male Breast Cancer Part 1, 2001.
- Brewster AM. Does Oral Contraceptive Use Increase the Risk of Breast Cancer?, 2001.
Abstracts
- Pande M, Bondy ML, Do KA, Sahin AA, Ying J, Mills GB, Thompson PA, Brewster AM. Association between germline single nucleotide polymorphisms in the PI3K-AKT-mTOR pathway, obesity, and breast cancer disease-free survival. AACR Annual Meeting, 2014, 2014.
- Atkinson RL, Symmans W, Bevers TB, Woodward WA, Brewster AM. Prevalence of breast stem cells in high-risk benign breast lesions and association with breastfeeding. AACR Annual Meeting, 2014, 2014.
- Basen-Engquist K, Murray JL, Brewster A, Schembre S, Song J, Gutierrez AM, Arun B. Randomized pilot study of a weight gain prevention intervention for breast cancer patients receiving neoadjuvant chemotherapy. AACR Frontiers in Cancer Prevention meeting, 2014, 2014.
- Gole P, Ying J, heriault R, Melhem-Bertrand A, Moulder S, Bedrosian I, Tereffe W, Black S, McNeil L, Giordano S, Pini M, Brewster AM. Ethnic disparities in adherence to breast cancer survivorship care. ASCO Breast Cancer Symposium 120(6):894-900, 2013. e-Pub 2013.
- Nimmons S, Bambhroliya A, Bevers T, Ying J, Brown P, Cook E, Newman L, Brewster A. The evaluation of breast cancer chemoprevention uptake in a high-risk cohort. AACR Frontiers of Cancer Prevention Meeting, 2013.
- Atkinson RL, El-Zien R, Fouad T, Bondy M, Ueno NT, Woodward WA, Brewster A. Epidemiological risk factors associated with the inflammatory breast cancer subtypes. San Antonio Breast Symposium, 2013.
- Brewster AM, Bondy M, Do K, Sahin A, Hale K, Wei C, Mills G, Thompson P. The association between germline genetic variants in the P13K mutations in breast tumors. AACR Frontiers of Cancer Prevention Meeting, 2012.
- Bayraktar, S, Thompson,PA, Yoo, SY, Do, K, Sahin, AA, Arun, BK, Bondy, ML, Brewster, AM. Prognostic relevance of eight genome wide association studies-identified single-nucleotide polymorphisms in primary breast cancer. AACR Frontiers of Cancer Prevention Meeting, 2011.
- Murray, JL, Thompson, P, Zhou, R, Yoo, SY, Liu, Y, Do, K, Sahin, A, Bondy, M, Brewster. AM.. Prognostic value of single nucleotide polymorphisms (SNPs) of candidate genes associated with inflammation in early stage breast cancer. ASCO Meeting, 2011.
- Brewster, AM, Parker, P, Bedrosian, I, Dong, W, Peterson, S, Cantor, S, Crosby, M, Shen, Y. The association between contralateral prophylactic mastectomy and breast cancer survival outcomes. ASCO Meeting, 2011.
- Brewster AM, Thompson P, Do KA, Sahin a, Zhang L, Murray JL, Tsachavidis S, Mills GB, Bondy M. Investigation of ethnic differences in the prevalence of chromosomal number aberrations of luminal and triple-negative breast cancers associated with risk of recurrence. ASCO Meeting Abstracts, 2010.
- Thompson P, Do K, Brewster AM, Shim J, Murray JL, Tsachavidis S, Sahin A, Mills GB, Bondy M. Integration of specific copy number imbalances and prediction models of early-stage breast cancer recurrence. ASCO Meeting Abstracts, 2010.
- Bambhroliya A, Bondy M, Thompson P, Sahin A, Murray JL, Zhou R, Sexton K, Brewster AM. Epidemiologic risk factors associated with breast cancer subtypes. ASCO Meetiing Abstracts, 2010.
- Murray JL, Thompson P, Tuna M, Brewster AM, Do K, Edgerton ME, Sahin A, Mills GB, Tsachavdis S, Bondy M. Association of gene copy number alterations in formalin-fixed, paraffin-embedded tumors with prognostic molecular and pathologic tumor subtypes in early-stage breast cancer. ASCO Meeting Abstracts, 2010.
- Brewster AM, Martinez E, Thompson P, Zhou R, Stewart M, Sahin A, Edgerton M, and Bondy M. The relationship between physical activity, obesity and breast cancer characteristics among Mexican American and African American women. Second American Association for Cancer Research, The Science of Cancer Health Disparities Conference; 2009. February 3-6; Carefree, AZ. Philadelphia (PA): AACR; 2009, Abstract No. B44, 2009.
- Meza MM, Martinez ME, Thompson P, Komenaka I, Gutierrez LE, Bondy M, Brewster AM, Edgerton M, Hortobagyi G, Sahin A, Daneri A, Jimenez M, Aramburo I, Caire G, Ortiz M, Perez L, Salazar O, Chavez M, Ornelas J, Gomez A, Morgan G, Vazquez G, Flores MR, Castro JM. The Ella Binational Breast Cancer Study: Risk factor and tumor marker profile in women of Mexican ancestry. Second American Association for Cancer Research, The Science of Cancer Health Disparities Conference, 2009.
- R. Zenuk, P. Thompson, J,. Nodora, G.Cruz, A. Brewster, M. Bondy, M. Stewart. M. Edgerton, A. Sahin, J. Murray, ME Martinez. Breast cancer detection and screening mammography in Mexican American women: Findings from the Ella Binational Breast Cancer Study, 2009.
- Dominici LS, Mittendorf EA, Liu J, Kuerer HM, Hunt KK, Brewster A, Babiera G, Meric-Bernstam F, Yu TK, Bedrosian I. Implications of constructed biologic subtype and its relationship to locoregional recurrence following mastectomy, 2009.
- Brewster A. M, Etzel C., Zhou R., Wong Y., Edge S. B., Blayney D. W., Wilson J., Hudis C., Weeks J. C., Theriault R. L.. The impact of obesity on adherence to the National Comprehensive Cancer Network (NCCN) guidelines recommending chemotherapy for patients with operable breast cancer, 2009.
- Brewster AM, Thompson PA, Cao Y, James LM, Stewart MM, Berry DA, Bondy ML. Method of detection is a prognostic factor for outcome among women diagnosed with early stage breast cancer. San Antonio Breast Cancer Symposium. Abstract No. 551824, 2008.
- Brewster AM, Hortobagyi GN, Broglio KR, Kau S-W, Santa-Maria CA, Arun B, Buzdar AU, Booser DJ, Valero V, Bondy M, Esteva FJ. Residual risk of breast cancer recurrence 5 years after adjuvant therapy. In: Proceedings of the 99th Annual Meeting of the American Association for Cancer Research; 2008 Apr 12-16; San Diego, CA. Philadelphia (PA): AACR; 2008. Abstract No. 3031, 2008.
- Brewster AM, Gorlov I, Yang W, Wang L, Bondy M, Carkaci S, Armstrong G, Pugh T, DeFreese D, Gramling B, Manjeshwar S, Shimasaki C, Jupe E. Epidemiological and genetic determinants of mammographic density. In: Proceedings of the Sixth AACR Interanational Conference on Frontiers in Cancer Prevention Research; 2007 Dec 5-8; Phliadelphia, PA, Philadelphia (PA): AACR; 2007. Abstract nr B104, 2007.
- Johnson CM, Ensor J, Broglio KR, Smolenski D, Ravdin P, Amos C, Meric-Bernstam, Brewster A, Bevers T, Arun B, Berry D. Building a predictive breast cancer risk model. AMIA Annual Symp Proc. Abstract No. M-105, 2007.
- Brewster AM, Do K, Thompson PA, Hahn KM, Sahin AA, Cao Y, Stewart MM, Murray JL, Hortobagyi GN and Bondy ML. Epidemiological risk factors for breast cancer recurrence according to estrogen and progesterone receptor status. In: Proceedings of the 98th Annual Meeting of the American Association for Cancer Research; 2007 Apr 14-18; Los Angeles, CA. Philadelphia (PA): AACR; 2007. Abstract nr 2609, 2007.
- Litton JK, Gonzalez-Angulo AM , Warneke CL, Kau S, Buzdar AU, Bondy M, Mahabir AM, Hortobagyi GN, Brewster AM. The relationship between obesity and pathologic response to neoadjuvant chemotherapy among women with operable breast cancer. Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings Part I. Vol 25, No. 18S (June 20 Supplement), 2007: 531, 2007.
- Brewster AM, Lee JJ, Clayman GL, Clifford JL, Necesito-Reyes MJ, Zhou X, Sabichi AL, Strom SS, Collins R, Meyers CA, Lippman SM. Phase III trial of adjuvant 13-cis-retinoic acid and interferon-alpha for patients with aggressive skin squamous cell carcinoma. In: Proceedings of the 97th Annual Meeting of the American Association for Cancer Research; 2006 Apr 1-5; Washington, DC. Philadelphia (PA): AACR; 2006. Abstract nr 5659, 2006.
- Lu J, Wei Q, Bondy ML, Wang L, Li D, Brewster A, Yu T-K, Sahin A, Meric-Bernstam F, Hunt KK, Singletary SE, Ross MI, Wang L-E. Polymorphisms and haplotypes of the NBSI gene associated with risk of sporadic breast cancer in young women: A case-control study. In: Proceedings of the 97th Annual Meeting of the American Association for Cancer Research; 2006 Apr 1-5; Washington, DC. Philadelphia (PA): AACR; 2006. Abstract nr 2040, 2006.
- Ruczinski I, Jorgensen TJ, Brewster AM, Helzlsouer KJ. Statistical inference in gene association studies of cancer risks with partially missing family history data. In: Proceedings of the 97th Annual Meeting of the American Association for Cancer Research; 2006 Apr 1-5; Washington, DC. Philadelphia (PA): AACR; 2006. Abstract nr 5369, 2006.
- Brewster AM, El-Zein R, Hajek R, Hernandez MS, Gor B, Jones LA. Low fat diet and oxidative damage. In: Proceedings of the 97th Annual Meeting of the American Association for Cancer Research; 2006 Apr 1-5; Washington, DC. Philadelphia (PA): AACR; 2006. Abstract nr B13, 2006.
- Rivera E, Mejia JA, Arun A, Adinin R, Walters R, Brewster AM, Broglio K, Yin G, Esteva FG, Hortobagyi GN, Valero V. Phase III study of docetaxel weekly (DW) versus every 3 weeks (D) in patients with metastatic breast cancer: Final results. Journal of Clinical Oncology, 2006 ASCO Annual Meeting Proceedings Part I. Vol 24, No. 18S (June 20 Supplement), 2006: 574, 2006.
- Visvanathan K, Santor D, Ali S, Brewster AM, Arnold A, Armstrong D, Helzlsouer K. The reliability of ductal lavage in women at high risk for breast cancer. Journal of Clinical Oncology, 2005 ASCO Annual Meeting Proceedings. Vol 23, No. 16S, Part I of II (June 1 Supplement), 2005: 1001, 2005.
- Rivera E, Valero V, Francis D, Meyers C, Brewster AM, Groves M, Royce M, Esteva F, Soto E, Murray JL, Pusztai L, Hortobagyi GN. The University of Texas M. D. Anderson Cancer Center, Houston, TX. Phase I study of capecitabine in combination with temozolomide in the treatment of patients with brain metastases from breast carcinoma. San Antonio Breast Cancer Symposium. Abstract No. 1079, 2004.
- Shi Q, Wang L-E, Bondy ML, Brewster A, Singletary E, Wei Q. DNA repair capacity for benzo[a]pyrene diol epoxide-induced adducts, common XPD polymorphisms, and breast cancer. In: Proceedings of the 95th Annual Meeting of the American Association for Cancer Research; 2004 Mar 27-31; Orlando, FL. Philadelphia (PA): AACR; 2004. Abstract nr 2891, 2004.
- Esteva FJ, Madden TL, Lammey J, Symmans WF, Booser DJ, Arun B, Rivera E, Brewster AM, Valero V, Hortobagyi GN. Phase I and pharmacokinetic (PK) study of oblimersen, a proapoptotic Bcl-2 targeting oligonucleotide, in combination with doxorubicin and docetaxel in metastatic and locally advanced breast cancer (BC). Journal of Clinical Oncology, 2004 ASCO Annual Meeting Proceedings (Post-Meeting Edition). Vol 22, No 14 S (July 15 Supplement), 2004: 3117, 2004.
Book Chapters
- Barcenas CH, Brewster AM. Overview of Breast Cancer Survivorship Management Guidelines. In: Breast Cancer, MD Anderson Cancer Care Series, 2015.
- Brewster AM, Davidson NE, McCaskill-Stevens W. Chemoprevention for Breast Cancer: Overcoming Barriers to Treatment. In: Am Soc Clin Oncol Educ Book. American Society of Clinical Oncology: Alexandria, VA, 85-90, 2012.
- Brewster A and Bondy M. Clinical and Molecular Epidemiology of Breast Cancer. In: Molecular Oncology of Breast Cancer. Jones & Bartlett Publishers, 2005.
- Brewster AM, Hortobagyi GN. Locally Advanced Breast Cancer. In: The Breast: Comprehensive Management of Benign and Malignant Disorders. Elsevier, 2003.
- Brewster A and Davidson N. Breast cancer screening. In: Handbook of Women's Health. Cambridge University Press, 383-398, 2001.
Letters to the Editor
- Litton Jennifer K. Brewster Abenaa M.. "Weight loss after breast cancer diagnosis may not improve prognosis". Journal of Clinical Oncology: 830-831, 2009.
Patient Reviews
Photo Gallery
